Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma
WF Hsu, YC Lin, IP Chiang… - Digestive and Liver …, 2021 - dldjournalonline.com
A 67-year-old man was diagnosed with hepatocellular carcinoma (HCC), cT4N1M1. The
patient agreed to receive the first dose of nivolumab 120 mg (2.4 mg/kg) before sorafenib …
patient agreed to receive the first dose of nivolumab 120 mg (2.4 mg/kg) before sorafenib …
Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma
WF Hsu, YC Lin, IP Chiang… - Digestive and liver …, 2021 - pubmed.ncbi.nlm.nih.gov
Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma
Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma …
Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma …
[引用][C] Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma.
WF Hsu, YC Lin, IP Chiang, CY Peng - … for the Study of the Liver, 2020 - europepmc.org
Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular
carcinoma. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
carcinoma. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …